Vic Pirotsky has an exceptional track record in drug development, regulatory strategy, and life sciences investments. His diverse experience includes senior roles, such as asset lead at the Gates Foundation, Pfizer, Boehringer Ingelheim, Alnylam, and portfolio director at atai Life Sciences. He has demonstrated outstanding leadership in bringing therapeutics to market, having led over eight successful New Drug Applications (NDAs). With a portfolio featuring blockbuster and breakthrough therapeutics across therapeutic areas, including rare diseases, oncology, and nephrology, his expertise in life-sciences due diligence and investments, combined with operational experience in pharmaceutical and biotech enterprises, provides unique insights into pharmaceutical development and commercialization. Vic was part of the early leadership for the Cancer Moonshot initiative, a national effort to accelerate cancer research, prevention, diagnosis, and treatment. He believes it is time for an “Addiction Moonshot” collaboration between government agencies and business leaders.
Board Member